Skip to search formSkip to main contentSkip to account menu

MACOP-B regimen

Known as: Methotrexate-Adriamycin-Cytoxan-Oncovin-Prednisone-Bleomycin Regimen 
A regimen consisting of methotrexate, bleomycin, doxorubicin, cyclophosphamide, vincristine and prednisone, used to treat aggressive forms of non… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
PURPOSE To investigate the incidence, natural history, and risk factors predictive of CNS relapse in patients with de novo… 
Review
2004
Review
2004
BACKGROUND Optimal therapeutic management of intravascular lymphoma (IVL) lacks precise guidelines. PATIENTS AND METHODS The… 
Highly Cited
2004
Highly Cited
2004
An extensive analysis of the reliability of positron emission tomography (PET) after induction treatment in patients with Hodgkin… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND We compared a regimen of six chemotherapeutic agents administered sequentially at high doses, followed by… 
Highly Cited
1993
Highly Cited
1993
BACKGROUND CHOP is a first-generation, combination-chemotherapy regimen consisting of cyclophosphamide, doxorubicin, vincristine… 
Highly Cited
1993
Highly Cited
1993
PURPOSE To evaluate the clinical features of presentation, the morphologic and immunohistochemical pattern, the modality of… 
Highly Cited
1991
Highly Cited
1991
One hundred twenty-six patients with diffuse large-cell lymphoma were treated with methotrexate with leucovorin, doxorubicin… 
Highly Cited
1990
Highly Cited
1990
While diffuse large-cell lymphoma (DLCL) is considered to be highly curable with current therapy, treatment failures are observed… 
Highly Cited
1988
Highly Cited
1988
Between 1981 and 1986, we treated 179 newly diagnosed patients with advanced-stage malignant lymphoma or related conditions with… 
Highly Cited
1985
Highly Cited
1985
Between April 1981 and May 1984, 61 patients with advanced diffuse large-cell lymphoma completed treatment with MACOP-B…